Monte carlo clinical dosimetry  by Sánchez-Doblado, Francisco et al.
Sánchez-Doblado et al.: Monte Carlo Clinical Dosimetry 
Rep. Pract. Oncol. Radiother. 7 (2) 2002 
MONTE CARLO CLINICAL DOSIMETRY  
 
 
Francisco Sánchez-Doblado1, 2, Antonio Leal1, 2, María Perucha1, 
Rafael Arráns2, Luis Núñez3, Joan V. Roselló4, Beatriz Sánchez-Nieto1, 
Ester Carrasco1, Antonio Gonzalez4, Juan C. Medrano3, Luis Errazquin2 
and José A. Sánchez-Calzado2 
 
 
1 Dpto. de Fisiología Médica y Biofísica. Facultad de Medicina. Universidad de Sevilla. 
  Avda. Sánchez Pizjuan, 4 E-41009 Sevilla. Spain 
2 Hospital Universitario Virgen Macarena. Sevilla. Spain 
3 Clínica Puerta de Hierro. Madrid. Spain 
4 Hospital General. ERESA. Valencia. Spain 
 
Received September 5th, 2001; received in a revised form February 27th, 2002; accepted March 11th, 
2002 
 
ABSTRACT 
 
   The choice of the most appropriate strategy for radiotherapy treatment is mainly based on the use 
of a planning system. With the introduction of new techniques (conformal and/or small fields, 
asymmetrical and non coplanar beams, true 3D calculation, IMRT) the trustworthiness of the algo-
rithms used is questioned. An alternative verification procedure has become increasingly more nece-
ssary to warranty treatment delivery. 
   The reliability of the Monte Carlo method is generally acknowledged. However, its clinical use has 
not been practical due to the high CPU time required. During the last few years our objective has 
decreased CPU time by means of a new process distribution technique. This reduction has made 
it feasible, not only to apply physical dosimetry under special conditions, but also to use it in numerous 
clinical cases employing photon and electron conformal fields, in radiosurgery, and IMRT. 
   The procedure carried out is presented. Furthermore, conventional Treatment Planning System 
calculations are compared with the Monte Carlo simulations.  
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INTRODUCTION 
 
   The usual way to implement a data set 
for calculations in a conventional treatment 
planning system (TPS) is to use dosime-
trical data measured with a water phantom 
in a linac room. However, in many cases 
the fields employed may be irregular 
or very small. In addition, detectors can 
have their limitations. Generally, the algo-
rithms utilized in a conventional TPS pro-
vide results that are adequate in standard 
situations, but in some special cases new 
modifications of the algorithms and new 
empirical data must be considered [1-6].  
   The Monte Carlo (MC) method allows us 
to simulate the real particle transport using 
exact linac geometry [7]. In our case, 
we have used the MC from the beginning 
of the process (the simulation of the linac) 
to the end (energy deposition at any ana-
tomical voxel) [8].  
   To overcome the CPU time drawback 
we have considered the following state-
ment: “as any particle history is indepen-
dent, the work can be distributed between 
different CPUs”. The first trials were ca-
rried out on two different Silicon Graphics 
computers: an O2 and a dual processor 
Octane workstation. Later, we implemen-
ted the code in a new 24 processor HP 
machine for which we have priority ac-
cess, which however was a very expen-
sive solution. Therefore we have develo-
ped a PC distributed process that permits 
us to obtain, at a low price, a crucible re-
duction in the CPU time. The multipro-
cessor technique is specially suitable 
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in Radiosurgery or Intensity Modulation, 
because the whole treatment can be divi-
ded into several beams which can be sent 
to different CPUs. With this tool we can ve-
rify, by means of the MC method, any phy-
sical or clinical dosimetry technique [9-11].  
 
MATERIAL AND METHODS 
 
   Thanks to the cooperation with the Engi-
neering School of the University of Seville 
we had access, during non-working hours, 
to a computer classroom with standard 
PCs connected to our server (Pentium III 
500 MHz type). No software (MC code, 
Operative System, data, etc.) had to be 
installed. The computer consisted of a ser-
ver and 36 CPUS (Pentium II, with 68 Mb 
of RAM).  
   Conventional (commercial) Treatment 
Planning Systems (TPS) used for compa-
rison were: Levinger-Fisher (Radiosur-
gery), Helax (IMRT) and Focus (Conformal 
Photon beams).  
   We used linacs: one from Siemens (Pri-
mus) and two from Elekta (SL18 and SL18 
with MLC).  
   We have implemented the OMEGA 
BEAM MC code distributed by Dave Roger 
from the NRC of Canada [12-14]. The Li-
nac head was simulated using different 
BEAM geometrical modules (e.g. FLAT-
FILT, CHAMBER, MIRROR, JAWS, MLC, 
etc), so that it was not necessary to gene-
rate any other additional geometry. Below 
the last module we added an air layer 
(using SLABS module) lying inferiorly on 
a linac reference point of a known distance 
to the target. 
   A Phase Space Data (PSD) was placed 
just below the MIRROR module. The PSD 
is a plane, which stores the position, angle 
of incidence and instant energy of all 
the particles in the beam. The file containing 
the PSD allows us to generate all the beam 
information from the target to the mirror. 
The PSD file is unique for each energy 
as the geometry above the mirror is 
the same for all cases. This PSD was used 
as an input to simulate any field confi-
guration including MLC, any additional co-
llimator for radiosurgery or blocks for con-
ventional conformal therapy. The result 
is a second PSD. With this PSD, we can 
study a physical situation in a phantom, 
obtaining dosimetric curves or isodose dis-
tributions. As a reduction variance techni-
que, we used the uniform bremsstrahlung 
splitting (UBS) in order to maintain the sa-
me statistical weight, with 25 splitted pho-
tons resulting from each bremsstrahlung 
interaction. Neither the photon interaction 
forcing nor the range rejection were acti-
vated. The fact that all particles in the PSD 
have the same statistical weight is essential 
to relate monitor units to the number of par-
ticles.  
   The last part of the simulation was carried 
out using a DOSXYZ code, which produced 
a dose map. Each beam was simulated 
from the corresponding phase space file, 
starting below the air layer up to the phan-
tom or patient, which was represented by 
a density distribution. This density distribu-
tion file was built from the CT information, 
taking under consideration 4 different mate-
rials (bone, tissue, lung, and air) and 4096 
different density levels. Slice resolution was 
512 x 512 pixels of 0.0853 cm, slices spa-
ced every 0.3 cm. Patient densities were 
distributed in a total number of 256 x 256 
x 80 voxels of 0.1706 x 0.1706 x 0.3 cm3 
each. We used resolutions raging from 0.1 
by 0.1 by 0.1 cubic millimetre in the case 
of endovascular brachytherapy up to 4 
by 4 by 4 cubic mm in the case of a simple 
PDD curve. The CT has been calibrated 
to correlate the Hounsfield number with 
the medium and physical density. Some 
treatment characteristics for CT and Pha-
se Space Data are presented in table 1. 
 
 
Tab. 1. Treatment characteristics for radiosurgery and IMRT simulated with FMC. 
 
 PSD CT 
Radiosurgery  ~ 70 beams Slices: 50 - 80 
  Voxels: 256 x 256x (1 mm RC – 1.6 mm Abdomen) 
IMRT ~ 80 segments 4096 density levels 
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   The DVH information was accessed by 
a BIOPLAN (a user-friendly windows-based 
software developed by one of the authors 
for biological evaluation of treatments) 
to perform the calculations of Normal Tissue 
Complication Probability (NTCP) and Tu-
mour Control Probability (TCP). NTCP 
and TCP models implemented in BIOPLAN 
are described below. 
   NTCP values were estimated using 
the Lyman Kutcher-Burman Model [15] with 
Emami parameters [16]. As Emami data 
were extracted from 2-Gy/fraction clinical 
data, the tolerance doses (TD50) for radio-
surgery cases were corrected to account 
for fractionation using an alfa/beta of 3 Gy 
(typical of normal tissues). 
   To compute TCP, the Poisson model was 
used [17-18] with clinically acceptable para-
meters (α=0.5 Gy-1, α/β=4 Gy and clono-
genic cell density ϕcl= 106/cm3). 
 
RESULTS 
 
   In the last few years, we have been 
involved in the application of the Monte 
Carlo method to radiotherapy in a large 
variety of clinical cases. Some of them are 
presented in this paper. The first case 
represents treatment of an acoustic neuri-
noma with two isocenters of 6 and 2 arcs 
(figure 1), respectively. When compared 
with a conventional TPS, there were not 
any significant differences in the 50% 
isodose (where the dose was prescribed) 
but some discrepancies could be found 
elsewhere (figure 2).  
   We also want to emphasise the diffe-
rences in the penumbra of the beam be-
tween the Monte Carlo and a conventional 
TPS (figure 3).  
   The dose-volume histograms (DVHs) 
do not show significant differences be-
tween the MC and the conventional TPS 
in the target, but some discrepancies can 
be observed from a radiobiological point 
of view. Figure 4 shows the DVHs 
for the target calculated with the MC and 
the TPS, as well as the corresponding 
Tumour Control Probability (TCP) values. 
In this case, DVHs cross each other at ap-
proximately 12 Gy level, the MC predicting 
a larger cold region than the TPS as well 
as a larger region irradiated by higher 
doses. However, as TCP curves are not 
symmetrical, even very small cold areas 
may make the TCP decrease drastically 
without being compensated for by large 
hot regions. This explains why, in this ca-
se, the TCP calculated from the MC calcu-
lations is lower (24.9%) than that asso-
ciated with to the TPS (30.9%). Figure 5 
shows the DVHs for the organ at risk, 
calculated again by the MC and the TPS, 
as well as the corresponding NTCP 
calculations [19-20]. 
   In the case of a conformal photon beam 
for the prostate treated with 8 fields: 2 + 2 
lateral opposite fields and 2 + 2 anterior-
posterior fields (figure 6), it can be obser-
ved that in the target area the reprodu-
cibility is acceptable. However, an over-
dose in the femoral heads can be noticed 
in the MC simulation (figures 7 and 8). 
   Finally, a case of Intensity Modulation 
is presented. It was calculated using an In-
verse-Planning by Helax. The optimised 
treatment is composed of 7 fields in a full 
arc of 360 degrees and 43 segments.  
   From the PSD obtained at the short 
distance from the jaws, every MLC confi-
guration corresponding to each single seg-
ment was simulated by means of our PC 
distribution tool. The number of particles 
used in the resulting PSDs was made 
proportional to the corresponding MU 
number. Figure 9 shows the dose distri-
bution differences between the TPS and 
the MC in a patient. A discrepancy be-
tween isodose curves can be observed, 
probably due to the pubic symphysis inter-
face.  
   The actual times spent to simulate very 
complex radiosurgical treatments with 
36 PC took less than one hour. Some very 
complex treatments with IMRT techniques 
were simulated and led to a total time 
of approximately 5 hours.  
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Fig. 2. Comparison of isodose distribution between Monte Carlo (left) and a conventional TPS (right) for an acoustic 
schwannoma treatment at the target level.
Fig. 1. Schematic of the acoustic schwannoma treatment consisting of eight arcs and two isocentre. 
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Fig. 3. Comparison of isodose distribution between Monte Carlo (right) and a conventional TPS (left) for the acoustic schwannoma 
treatment at the field edge.
 
Fig 4. DVH of the target  (acoustic schwannoma) showing 
the differences in TCP when calculated with Monte Carlo 
(MC) and a conventional planning system (PL).
NTCP=0.6% 
NTCP=6.3% 
Fig. 5. DVH of the organ at risk  (brain stem) showing
the differences in NTCP when calculated with Monte Carlo 
(MC) and a treatment planning system (PL).
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Fig. 6. Schematic of the treatment showing the 4 + 4 technique.
Fig. 7. Dose distribution in the axial plane. The isodoses line are similar around the target. However, differences can be 
found between Monte Carlo (down) and a conventional TPS (up) on the 50% isodose. 
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Fig. 8. Dose distribution in the coronal plane. As like in figure 7, some differences can be found between Monte Carlo 
(down) and a conventional TPS (up) on the femoral heads.
Fig. 9. Dose distribution comparison between a conventional  TPS (up) and Monte Carlo (down) for a IMRT treatment. 
Some differences can be observed. It is noticeable the influence of the pelvic bone interfaces. 
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CONCLUSIONS 
 
   With this new procedure developed 
by our group we can confirm that the CPU 
time is adequate for MC verification. 
Considering this point of view the distribu-
ted process is perfectly suitable for MC 
calculations especially in radiosurgery 
and IMRT. 
   In this sense the distributed process is 
very suitable for MC calculation, especially 
in radiosurgery and IMRT.  
   The MC method represents a powerful 
tool for verification and conduction of pro-
cedures of mainly in atypical situations. 
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